WHI-P180

CAS No. 211555-08-7

WHI-P180( Janex 3 )

Catalog No. M13366 CAS No. 211555-08-7

WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
5MG 40 In Stock
10MG 61 In Stock
25MG 129 In Stock
50MG 184 In Stock
100MG 291 In Stock
200MG 434 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WHI-P180
  • Note
    Research use only, not for human use.
  • Brief Description
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
  • Description
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
  • In Vitro
    ——
  • In Vivo
    WHI-P180 is also an active inhibitor of IgE-mediated mast cell responses. The elimination half-life of WHI-P180 in CD-1 mice (BALB/c mice) following i.v., i.p., or p.o. administration is less than 10 min. Systemic clearance of WHI-P180 is 6742 mL/h/kg in CD-I mice and 8188 mL/h/kg in BALB/c mice. Notably, WHI-P180, when administered in two consecutive nontoxic i.p. bolus doses of 25 mg/kg, inhibits IgE/antigen-induced vascular hyperpermeability in a well-characterized murine model of passive cutaneous anaphylaxis.
  • Synonyms
    Janex 3
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK2| EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    211555-08-7
  • Formula Weight
    297.31
  • Molecular Formula
    C16H15N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    OC1=CC=CC(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)=C1
  • Chemical Name
    3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An R, et al. Pharm Res. 2009 Feb;26(2):449-58.
molnova catalog
related products
  • FN-1501

    FN-1501 is a potent FLT3 and CDK inhibitor (IC50s: 2.47, 0.85, 1.96, and 0.28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively).

  • Ryuvidine

    Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).

  • CDK7 and 9 inhibitor...

    A potent, selective transcriptional CDK inhibitor with Ki of 2.3 and 0.38 nM for CDK7 and CDK9, respectively; displays >30-fold selectivity over CDK1/2/4, inhibits VEGFR2 with IC50 of 180 nM in a panel of non-CDK kinases.